DNA

Ultima Genomics releases groundbreaking TRACERx MRD data showing ppmSeq performance and unveils clinical progress of whole genome sequencing at inaugural global MRD Symposium at AACR 2026

Presenting initial TRACERx MRD data showcasing low single-digit parts-per-million   sensitivity for ctDNA detection with ppmSeq Additional collaborations also demonstrate ultra-sensitive...

Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage

Three world-leading key opinion leaders, researchers and clinicians, join Clinical Advisory Board, reinforcing Bioxodes’ global registrational clinical strategy Positive ongoing discussions...

DRAGEN v4.5 supports Illumina’s new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

Illumina launches DRAGEN v4.5, unlocking deep biological signals in complex regions and challenging sample types for rare disease, oncology research...

Blood Cancer Patients and Their Supporters Cycle Across Iceland to Raise Funds and Awareness for Multiple Myeloma and the International Myeloma Foundation’s Research

3rd Annual Iceland Cycling Expedition from August 18-24, 2026, Aims to Fund Myeloma Prevention and a CureSTUDIO CITY, Calif., April...

Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients

Comprehensive molecular profiling paired with biomarker-driven trial matching provides cancer patients with a complete pathway from diagnosis to treatment across...

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial

78% Objective Response Rate (ORR) with PDS01ADC; Parallel trial without PDS01ADC had 35% ORR 2-year survival rate of >80%; Parallel...

OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies

Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease

Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care. SAN DIEGO, April 14, 2026...

error: Content is protected !!